Showing results (421-430 of 968) with videos related to
Sort By:
Pageof 97
Deutsche Medizinische Wochenschrift (1946)|April 11, 1997
[Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods]T M Behr, D M Goldenberg, J R Scheele, et al.Differentiation; Research in Biological Diversity|January 1, 1986
Retention of lens specificity in long-term cultures of diploid rabbit lens epithelial cellsJ R Reddan, A B Chepelinsky, D C Dziedzic, et al.Small (Weinheim an Der Bergstrasse, Germany)|September 6, 2007
Large-scale synthesis of organophilic zirconia nanoparticles and their application in organic-inorganic nanocomposites for efficient volume holographyGeorg Garnweitner, Leonid M Goldenberg, Oksana V Sakhno, et al.Blood|April 18, 2009
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphomaEdmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1994
Lack of association between ovarian follicular size and number and the occurrence of multiple pregnancies in menotropin cyclesM Goldenberg, J Rabinovici, J Shalev, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 3, 2014
Examining negative effects of early life experiences on reproductive and sexual health among female sex workers in Tijuana, MexicoKarishma K Oza, Jay G Silverman, Ietza Bojorquez, et al.Cancer Research|September 30, 2010
A bispecific antibody-IFNalpha2b immunocytokine targeting CD20 and HLA-DR is highly toxic to human lymphoma and multiple myeloma cellsEdmund A Rossi, Diane L Rossi, Rhona Stein, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivoR Stein, D M Goldenberg, G L Ong, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982
Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigenE Mizusawa, H L Dahlman, S J Bennett, et al.Cancer|December 24, 1997
Can occult metastases be treated by radioimmunotherapy?R M Dunn, M Juweid, R M Sharkey, et al.Pageof 97